4//SEC Filing
McGrane Nicholas 4
Accession 0001628908-19-000010
CIK 0001628908other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:50 PM ET
Size
7.3 KB
Accession
0001628908-19-000010
Insider Transaction Report
Form 4
McGrane Nicholas
Chief Financial Officer
Transactions
- Award
Class A Common Stock Option (right to buy)
2019-03-01+57,741→ 57,741 totalExercise: $13.29Exp: 2029-03-01→ Class A Common Stock (57,741 underlying) - Award
Class A Common Stock
2019-03-01+30,098→ 84,088 total
Footnotes (4)
- [F1]Represents restricted stock units granted to Mr. McGrane pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
- [F2]Securities vest at a rate of 25% annually beginning March 1, 2020.
- [F3]Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F4]Securities vest at a rate of 25% annually beginning March 1, 2020.
Documents
Issuer
Evolent Health, Inc.
CIK 0001628908
Entity typeother
Related Parties
1- filerCIK 0001643086
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:50 PM ET
- Size
- 7.3 KB